HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Ro 48-8587

structure in first source

Also Known As:

9-imidazol-1-yl-8-nitro-2,3,5,6-tetrahydro(1,2,4)triazolo(1,5-c)quinazoline-2,5-dione

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Imidazoles: 150
      - Ro 48-8587: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinazolines: 402
      - Ro 48-8587: 1

Experts

1.	Di Paolo, Thérèse: 1 article (10/2013)
2.	Gasparini, Fabrizio: 1 article (10/2013)
3.	Gomez-Mancilla, Baltazar: 1 article (10/2013)
4.	Grégoire, Laurent: 1 article (10/2013)
5.	Morin, Nicolas: 1 article (10/2013)
6.	Morissette, Marc: 1 article (10/2013)

Related Diseases

1.	Dyskinesias (Dyskinesia) 10/01/2013 - "Elevated basal ganglia specific binding of [(3)H]Ro 25-6981 (NMDA NR1/NR2B receptors), [(3)H]Ro 48-8587 (AMPA receptors) but not [(3)H]CGP-39653 (NMDA NR1/NR2A receptors) was observed only in L-DOPA-treated MPTP monkeys; dyskinesias scores correlated with binding. "

Related Drugs and Biologics

1.	AMPA Receptors (AMPA Receptor)
2.	N-Methylaspartate (NMDA)
3.	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)
4.	Levodopa (L Dopa)
5.	Ro 25-6981
6.	CGP 39653